140 related articles for article (PubMed ID: 19136774)
1. Utility of fibronectin in immuocytochemial differentiation of reactive mesothelial cells from metastatic malignant cells in serous effusions.
Agarwal C; Jain M
Indian J Pathol Microbiol; 2009; 52(1):25-8. PubMed ID: 19136774
[TBL] [Abstract][Full Text] [Related]
2. Immunocytochemical differentiation of reactive mesothelial cells and adenocarcinoma cells in serous effusions with the use of carcinoembryonic antigen and fibronectin.
Athanassiadou P; Athanassiades P; Lazaris D; Kyrkou K; Petrakakou E; Aravantinos D
Acta Cytol; 1994; 38(5):718-22. PubMed ID: 8091904
[TBL] [Abstract][Full Text] [Related]
3. Moc-31, fibronectin and CEA in the differential diagnosis of malignant effusions: an immunocytochemical study.
Athanassiadou P; Gonidi M; Liossi A; Petrakakou E; Nakopoulou L; Zerva C; Athanassiades P
Pathol Oncol Res; 2000; 6(2):100-3. PubMed ID: 10936783
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical panel for distinguishing between carcinoma and reactive mesothelial cells in serious effusions.
Lee JS; Nam JH; Lee MC; Park CS; Juhng SW
Acta Cytol; 1996; 40(4):631-6. PubMed ID: 8693877
[TBL] [Abstract][Full Text] [Related]
5. Immunophenotyping of mesothelial cells and carcinoma cells with monoclonal antibodies to cytokeratins, vimentin, CEA and EMA improves the cytodiagnosis of serous effusions.
Daste G; Serre G; Mauduyt MA; Vincent C; Caveriviere P; Soleilhavoup JP
Cytopathology; 1991; 2(1):19-28. PubMed ID: 1715202
[TBL] [Abstract][Full Text] [Related]
6. Immunocytochemical panel for the identification of malignant cells in serous effusions.
Nance KV; Silverman JF
Am J Clin Pathol; 1991 Jun; 95(6):867-74. PubMed ID: 1710419
[TBL] [Abstract][Full Text] [Related]
7. [Significance of combining detection of E-cadherin, carcinoembryonic antigen, and calretinin in cytological differential diagnosis of serous effusion].
Su XY; Li GD; Liu HB; Jiang LL
Ai Zheng; 2004 Oct; 23(10):1185-9. PubMed ID: 15473932
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic value of E-cadherin and fibronectin in differentiation between reactive mesothelial and adenocarcinoma cells in serous effusions.
Moghaddam NA; Tahririan R; Eftekhari M; Tahririan D; Rahmani A
Adv Biomed Res; 2012; 1():56. PubMed ID: 23326787
[TBL] [Abstract][Full Text] [Related]
9. Ber-EP4 for differentiating adenocarcinoma from reactive and neoplastic mesothelial cells in serous effusions. Comparison with carcinoembryonic antigen, B72.3 and Leu-M1.
Bailey ME; Brown RW; Mody DR; Cagle P; Ramzy I
Acta Cytol; 1996; 40(6):1212-6. PubMed ID: 8960030
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic utility of CD44 standard, CD44v6, and CD44v3-10 expression in adenocarcinomas presenting in serous fluids.
Afify A; Pang L; Howell L
Appl Immunohistochem Mol Morphol; 2007 Dec; 15(4):446-50. PubMed ID: 18091389
[TBL] [Abstract][Full Text] [Related]
11. Significance of epithelial membrane antigen in the work-up of problematic serous effusions.
Singh HK; Silverman JF; Berns L; Haddad MG; Park HK
Diagn Cytopathol; 1995 Jul; 13(1):3-7. PubMed ID: 7587872
[TBL] [Abstract][Full Text] [Related]
12. Utility of anti-L523S antibody in the diagnosis of benign and malignant serous effusions.
Hanley KZ; Facik MS; Bourne PA; Yang Q; Spaulding BO; Bonfiglio TA; Xu H
Cancer; 2008 Feb; 114(1):49-56. PubMed ID: 18098206
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic significance of carcinoembryonic antigen levels in serous effusions. Correlation with cytology.
Whiteside TL; Dekker A
Acta Cytol; 1979; 23(6):443-8. PubMed ID: 295160
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical differentiation of malignant mesothelioma, mesothelial hyperplasia and metastatic adenocarcinoma in serous effusions, utilizing staining for carcinoembryonic antigen, keratin and vimentin.
Duggan MA; Masters CB; Alexander F
Acta Cytol; 1987; 31(6):807-14. PubMed ID: 2447718
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic value of p53 protein and flow cytometric DNA analysis in the study of serous effusions.
Lee JS; Lee MC; Park CS; Juhng SW
Acta Cytol; 1997; 41(6):1719-25. PubMed ID: 9390131
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic utility of GLUT-1 expression in the cytologic evaluation of serous fluids.
Afify A; Zhou H; Howell L; Paulino AF
Acta Cytol; 2005; 49(6):621-6. PubMed ID: 16450901
[TBL] [Abstract][Full Text] [Related]
17. HBME-1 immunostaining in reactive mesothelial versus metastatic adenocarcinoma cells in serous fluid.
Rahmani A; Dehghani MZ; Afshar NM; Heidarian H; Tahririan R
Indian J Pathol Microbiol; 2011; 54(3):460-3. PubMed ID: 21934203
[TBL] [Abstract][Full Text] [Related]
18. Distinction between carcinoma cells and mesothelial cells in serous effusions. Usefulness of immunohistochemistry.
Tickman RJ; Cohen C; Varma VA; Fekete PS; DeRose PB
Acta Cytol; 1990; 34(4):491-6. PubMed ID: 2197840
[TBL] [Abstract][Full Text] [Related]
19. Immunocytochemistry in the differential diagnosis of serous effusions: a comparative evaluation of eight monoclonal antibodies in Papanicolaou stained smears.
Lozano MD; Panizo A; Toledo GR; Sola JJ; Pardo-Mindán J
Cancer; 2001 Feb; 93(1):68-72. PubMed ID: 11241268
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical distinction between mesothelial and adenocarcinoma cells in serous effusions: a combination panel-based approach with a brief review of the literature.
Murugan P; Siddaraju N; Habeebullah S; Basu D
Indian J Pathol Microbiol; 2009; 52(2):175-81. PubMed ID: 19332905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]